CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-16 | Zaderej Karen L. CEO | Option exercise · Restricted Stock Units | −84,847 | 84,847 | ||
| 2024-03-16 | Zaderej Karen L. CEO | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2024-03-16 | Zaderej Karen L. CEO | Option exercise · Restricted Stock Units | −12,975 | 0 | ||
| 2024-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +3,000 | 166,377 | ||
| 2024-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +2,950 | 168,611 | ||
| 2024-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +12,725 | 180,615 | ||
| 2024-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise · Restricted Stock Units | −3,000 | 0 | ||
| 2024-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise · Restricted Stock Units | −2,950 | 2,950 | ||
| 2024-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise · Restricted Stock Units | −12,725 | 12,725 | ||
| 2024-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise | +21,281 | 58,250 | ||
| 2024-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise | +4,125 | 57,124 | ||
| 2024-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise · Restricted Stock Units | −21,281 | 21,282 | ||
| 2024-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise · Restricted Stock Units | −4,125 | 4,125 | ||
| 2024-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise · Restricted Stock Units | −2,500 | 0 | ||
| 2024-03-16 | Donovan Michael Patrick VP Operations | Option exercise | +3,000 | 38,708 | ||
| 2024-03-16 | Donovan Michael Patrick VP Operations | Option exercise | +2,950 | 40,942 | ||
| 2024-03-16 | Donovan Michael Patrick VP Operations | Option exercise | +18,625 | 58,846 | ||
| 2024-03-16 | Donovan Michael Patrick VP Operations | Option exercise · Restricted Stock Units | −3,000 | 0 | ||
| 2024-03-16 | Donovan Michael Patrick VP Operations | Option exercise · Restricted Stock Units | −2,950 | 2,950 | ||
| 2024-03-16 | Donovan Michael Patrick VP Operations | Option exercise · Restricted Stock Units | −18,625 | 18,625 |
Page 14 of 61 · 1,220 trades